Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
2.820
+0.130 (4.83%)
At close: Sep 26, 2025, 4:00 PM EDT
2.810
-0.010 (-0.35%)
After-hours: Sep 26, 2025, 7:34 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $720.12 million as of September 26, 2025. Its market cap has decreased by -42.26% in one year.
Market Cap
720.12M
Enterprise Value
821.29M
1-Year Change
-42.26%
Ranking
Category
Stock Price
$2.82
Market Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $2.43B to $720.12M, a decrease of -70.36%. That is a compound annual growth rate of -22.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 407.99M | -47.22% |
| Dec 31, 2024 | 773.05M | -10.72% |
| Dec 29, 2023 | 865.84M | -54.00% |
| Dec 30, 2022 | 1.88B | -65.83% |
| Dec 31, 2021 | 5.51B | 100.45% |
| Dec 31, 2020 | 2.75B | 13.12% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 665.99B |
| Johnson & Johnson | 425.53B |
| AbbVie | 388.63B |
| UnitedHealth Group | 318.63B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 233.03B |